Major Responsibilities:

Responsible for the creation, update & execution of the Integrated Evidence Plans (IEP) of Remibrutinib across the indications Remibrutinib is developed in, ensuring the right evidence is available at the right time to enable access and clinical adoption.

Will act as a strategic partner to and close collaborator with Biomedical Research, Development, International Medical Affairs, US Medical Affairs, Strategy & Growth and Intl & US Commercial.

Skills and capabilities:

• 8+ years in Pharmaceutical Industry experience in Medical Affairs and/or Clinical Development, incl. global experience.
• Significant experience and expertise in evidence generation activities, such as interventional or non-interventional studies and RWE projects.
• Significant experience and expertise in the full range of medical affairs tactics with a deep understanding of health care systems and key external stakeholders such as Healthcare professionals (HCP), payers, medical societies and guideline committees.
• Understands unmet medical needs, generates the right evidence to effectively address them, uses innovative, multichannel communication formats for effective evidence dissemination.
• Strong external network within the indication space, credibility as peer expert with external stakeholders.
• Strategic mindset and able to establish credibility and influence across a range of diverse stakeholders in a matrix organization to drive change.
• A highly self-aware and inspiring leader who effectively leads large diverse teams (PMATs) in a complex matrix, demonstrating strong influencing skills. 
• Equipped with strong collaboration and negotiation skills, the GMA ED constructively resolves conflicts and removes barriers that get in the way of delivering results.

Languages :

• Strong English language skills are essential as are strong communication skills to deliver clear, targeted, and scientifically sound presentations to diverse internal, including senior management and external audiences.